Oxygen Dissociation Assay (ODA): spectrophotometric based screening platform for hemoglobin-O2 affinity modifiers
Oxygen dissociation assay (ODA) in a microplate: How to find modifiers of hemoglobin-oxygen affinity in high throughput?
Cardiovascular diseases are the number one cause of death globally and includes conditions such as arrhythmias, coronary heart disease (CHD), heart attack, high blood pressure, congenital heart defects, vascular dementia, and stroke. CHD is a complex condition and there are many pathways and processes involved in the pathogenesis of the disease, understanding the physiology of ischemia and reperfusion injury is one of the key area of clinical interest but it has been difficult to initiate, maintain and reverse acute hypoxic environments in in-vitro studies. BMG LABTECH’s CLARIOstar Plus reader with Atmospheric Control Unit (ACU) allow oxygen levels to be rapidly and precisely controlled to mimic normal in vivo conditions, ischemia or reperfusion events. Explore the content below to see how we can support ischemia-reperfusion research and cardiovascular research including investigation on what effects oxygen deprivation and reperfusion injury can have on cells, elucidating the role of various cellular processes and identifying potential drug targets to minimize the effects of patients suffering with CHD.
Search our resources section for information about specific applications, literature citations, videos, blog articles and many other publications. Many of the resources provided are associated with current and previous instrument models and versions.